In vitro splicing of pre-mRNA containing bromouridine.
The artificial UTP-analogue 5-bromouridine 5'-triphosphate (BrUTP) has been used to label pre-mRNA in vitro and in vivo [1,2]. We have investigated the effect of bromouridine (BrU) in pre-mRNA on the efficiency of splicing. An adenovirus major late II construct was used to prepare four different transcripts, each containing a different amount of BrU. These four transcripts were tested in an in vitro splicing assay. We found that splicing is strongly inhibited if all uridines (U) in the transcript were substituted for BrU. Splicing was restored to some extent if 50% of the Us were replaced by BrU. The splicing efficiency returned to an almost normal level if only 1 our of every 10 Us was substituted for BrU. This demonstrates that only a pre-mRNA containing a small amount of BrU can be spliced normally in vitro. Furthermore, these results strongly suggest that some Us in the adenoviral transcript, probably those at the splice sites, cannot be replaced by BrU and are therefore critical in the splicing reaction.
Wansink
D G
DG
E. C. Slater Institute, University of Amsterdam, The Netherlands.
Nelissen
R L
RL
de Jong
L
L
D000256:Adenoviridae / Q000235:genetics; D001483:Base Sequence; D001976:Bromouracil / Q000031:analogs & derivatives; D002474:Cell-Free System; D006367:HeLa Cells; D006801:Humans; D008969:Molecular Sequence Data; D012322:RNA Precursors / Q000378:metabolism; D012326:RNA Splicing / Q000187:drug effects*; D014529:Uridine / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology
D012322:RNA Precursors; D001976:Bromouracil; C006824:5-bromouridine; D014529:Uridine